5.51 USD
↗ 0.77 (16.25%)AT CLOSE (11:59 AM EDT)
Aligos Therapeutics, Inc. Common Stock
ALGSNASDAQ • USD
5.27
↘ 0.24 (4.36%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
5.27
↘ 0.24 (4.36%)
Market: CLOSED
ALGS is currently priced at $5.56. ALGS shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 6, 2026.
Open?$4.18
High?$5.60
Low?$4.18
Prev. Close?$4.74
Volume?293.5K
Avg. Volume?231.4K
VWAP?$5.18
Rel. Volume?1.27x
Bid / Ask
Bid?$5.26 × 400
Ask?$5.55 × 100
Spread?$0.29
Midpoint?$5.40
Valuation & Ratios
Market Cap?29.3M
Shares Out?5.4M
Float?4.8M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?0.92
EPS?-$14.60
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Themes
Employees
82
Market Cap
29.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-10-16
Address
ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?35
Short Sent.?53
Piotroski F-Score?2/9Weak
Altman Z-Score?-18.03Distress
Confidence?57%Low
Short InterestHigh
Short % of Float?10.84%High
Short Interest?521.4K
Days to Cover?1.0
Free Float4.8M
Avg Daily Volume514.2K
Settlement Date2026-07-15
Financial Health
Current Ratio?2.56Strong
Quick Ratio?2.56Strong
Cash Ratio?1.29Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?0.92CHEAP▾
Peers100
S&P97
P/S?6.23FAIR▾
Peers100
S&P20
P/FCF?N/A▾
EV/EBITDA?0.0CHEAP▾
Peers100
S&P97
EV/Sales?-0.12CHEAP▾
S&P97
Returns & Efficiency
ROE?-284.1%WEAK▾
S&P3
ROA?-139.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-85185000
Enterprise Value?$-565823
Fundamentals ratios updated end of day